Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer

To realize a machine learning (ML) model to estimate the dose of low molecular weight heparin to be administered, preventing thromboembolism events in COVID-19 patients with active cancer. Methods: We used a dataset comprising 131 patients with active cancer and COVID-19. We considered five ML model...

Descripción completa

Detalles Bibliográficos
Autores principales: Imbalzano, Egidio, Orlando, Luana, Sciacqua, Angela, Nato, Giuseppe, Dentali, Francesco, Nassisi, Veronica, Russo, Vincenzo, Camporese, Giuseppe, Bagnato, Gianluca, Cicero, Arrigo F. G., Dattilo, Giuseppe, Vatrano, Marco, Versace, Antonio Giovanni, Squadrito, Giovanni, Di Micco, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746167/
https://www.ncbi.nlm.nih.gov/pubmed/35011959
http://dx.doi.org/10.3390/jcm11010219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746167/
https://www.ncbi.nlm.nih.gov/pubmed/35011959
http://dx.doi.org/10.3390/jcm11010219

Ejemplares similares